The global market for veterinary immunodiagnostics is expected to grow substantially by 2027, according to a report by Research and Markets, which provides market insights and analysis around the world. Across the forecast period from 2023 and 2037, the market is expected to grow at a high CAGR, driven by the increased prevalence of zoonotic disease.
The market’s projected growth is also based on the increased rate of companion animal adoption. As a result of the higher numbers of pets, immunodiagnostics are being more commonly requested by pet owners.
Technological advancements in veterinary immunodiagnostics have also led to growth in the market.
The market segments provided in the report include animal and product type, technology, application, competitive landscape, end user, distribution channel and regional distribution.
Consumables are anticipated to hold the greatest share of the market across the 2023 to 2027 forecast period. This is thought to be due in part to increased awareness about animal healthcare.
The major market players operating in the global veterinary immunodiagnostics market include: Abaxis Inc., BioMerieux SA, Idexx Laboratories Corporation, Heska Corporation, Virbac SA, Zoetis Inc., Woodley Veterinary Diagnostics Ltd., Randox Laboratories Ltd., Neogen Corporation and Thermo Fisher Scientific Inc., among others.
Learn more about this veterinary immunodiagnostics report on Research and Market’s website.
List
Add
Please enter a comment